Bryan L. Roth

Bryan L. Roth publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Bryan L. Roth sits on this spectrum.

Bryan L. Roth D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Bryan L. Roth sits on this spectrum.

Research.com Recognitions

• 2026 - Research.com Neuroscience in United States Leader Award

Overview

Best Publications

• A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

  David E. Gordon;Gwendolyn M. Jang;Mehdi Bouhaddou;Jiewei Xu

  5396
  Citations

• Relating protein pharmacology by ligand chemistry

  Michael J. Keiser;Bryan L. Roth;Bryan L. Roth;Blaine N. Armbruster;Paul R Ernsberger

  2502
  Citations

• The Expanded Biology of Serotonin

  Miles Berger;John A. Gray;Bryan L. Roth

  2490
  Citations

• Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand

  Blaine N. Armbruster;Xiang Li;Mark H. Pausch;Stefan Herlitze

  2266
  Citations

• DREADDs for Neuroscientists.

  Bryan L. Roth

  2070
  Citations

• Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression

  Grazyna Rajkowska;José J Miguel-Hidalgo;Jinrong Wei;Ginny Dilley

  1913
  Citations

• Predicting new molecular targets for known drugs

  Michael J. Keiser;Vincent Setola;John J. Irwin;Christian Laggner

  1902
  Citations

• Rapid, reversible activation of AgRP neurons drives feeding behavior in mice

  Michael J. Krashes;Shuichi Koda;Chian Ping Ye;Sarah C. Rogan

  1678
  Citations

• Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

  Bryan L. Roth;Douglas J. Sheffler;Wesley K. Kroeze

  1355
  Citations

• Functional Selectivity and Classical Concepts of Quantitative Pharmacology

  Jonathan D. Urban;William P. Clarke;Mark Von Zastrow;David E. Nichols

  1317
  Citations

• Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

  David A. Shapiro;Sean Renock;Elaine Arrington;Louis A. Chiodo

  1249
  Citations

• Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors.

  Georgia M. Alexander;Sarah C. Rogan;Atheir I. Abbas;Blaine N. Armbruster

  1101
  Citations

• Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons

  Matthew S. Goldberg;Sheila M. Fleming;James J. Palacino;Carlos Cepeda

  1083
  Citations

• Structure of the human κ-opioid receptor in complex with JDTic

  Huixian Wu;Daniel Wacker;Mauro Mileni;Vsevolod Katritch

  1078
  Citations

• H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs

  Wesley Kars Kroeze;Sandra J. Hufeisen;Beth A. Popadak;Sean M. Renock

  1065
  Citations

• Structure-based discovery of opioid analgesics with reduced side effects

  Aashish Manglik;Henry Lin;Dipendra K. Aryal;John D. McCorvy

  1014
  Citations

• Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist

  Bryan L. Roth;Karen Baner;Richard Westkaemper;Daniel Siebert

  962
  Citations

• Ultra-large library docking for discovering new chemotypes

  Jiankun Lyu;Sheng Wang;Trent E. Balius;Isha Singh

  939
  Citations

• Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.

  B L Roth;S C Craigo;M S Choudhary;A Uluer

  927
  Citations

• Automated design of ligands to polypharmacological profiles

  Jérémy Besnard;Gian Filippo Ruda;Vincent Setola;Keren Abecassis

  907
  Citations

• The promise and peril of chemical probes.

  Cheryl H. Arrowsmith;James E. Audia;Christopher Austin;Jonathan Baell

  883
  Citations